NASDAQ:EYPT

EyePoint Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

EYPT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.40 $-0.35 $-0.30
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $9.84M $9.01M $15.70M

Eyepoint Pharmaceuticals, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

EYPT Earnings Date & History Chart

EYPT Earnings & Revenue Forecast

EYPT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.39 $-0.47 $-0.31
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-1.62 $-1.77 $-1.48
Dec 2022 5 $-1.58 $-2.50 $-1.09

EYPT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.39 $-0.41 $-0.40
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.62 $-1.65 $-1.73
Dec 2022 0 / 0 $-1.58 $-1.57 $-1.45

EYPT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $10.56M $9.50M $11.40M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $36.74M $35.20M $38.00M
Dec 2022 5 $54.23M $50.00M $59.50M

EYPT Earnings Date & Revenue History

EYPT Earnings History

|
Show More
Show More

EYPT Revenue History

|
Show More
Show More

Eyepoint Pharmaceuticals, Inc Next Earnings Date & Report

EYPT Next Earnings Date & Report Preview: Sep 2021 (FQ)

EYPT's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Eyepoint Pharmaceuticals, Inc's next quarterly earnings is $-0.40, with a low EPS estimation of $-0.47, and a high estimation of $-0.36.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.40, the last 2 month trend is $-0.41, and the 3 month trend is $-0.43.

Based on 5 analysts, the average revenue estimation is $9.84M, with a low revenue estimation of $9.30M, and a high estimation of $10.30M.

Eyepoint Pharmaceuticals, Inc Previous Earnings Dates & Reports

EYPT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Eyepoint Pharmaceuticals, Inc's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

EYPT's earnings per share (EPS) was $-0.35, beating the consensus analysts forecast of $-0.44 by 19.72%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -30.00%, and higher than the same period a year before (Jun 2020) by -65.00%.

Revenues were $9.01M, better than the forecast of $9.01M by 0.00%, up by 23.08% from the previous quarter , and up by 118.66% from the same period last year.

The company reported a net income of $-10.01M.

Free cash flow for the quarter was $-10.57M , compared to $-15.10M last quarter and $-5.15M a year before.

EYPT ended the quarter with $38.25M in total debt, a decrease of -5.08% compared to the previous quarter, and a decrease of -27.68% compared to the same quarter a year before.

EYPT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Eyepoint Pharmaceuticals, Inc's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.

EYPT's earnings per share (EPS) was $-3.47, missing the consensus analysts forecast of $-1.87 by 85.56% , and higher than the previous year's EPS (Dec 2019) by -38.04%.

Revenues were $34.44M, worse than the forecast of $47.74M by -27.87%, and up by 69.10% from previous year's revenue.

The company reported a net income of $-45.39M.

Eyepoint Pharmaceuticals, Inc reported a free cash flow of $-14.80M for its fiscal year, compared to $-56.91M a year ago.

The company ended the fiscal year with $46.31M in total debt, a decrease of -2.93% compared to the previous year.